SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as analysts raise price targets, anticipating strong AI demand and a potential trade deal with China that could unlock significant market share. The community is buzzing about NVIDIA's potential to become the first $5 trillion company, fueled by new partnerships and positive commentary around AI's transformative impact. Some traders caution about valuation concerns and potential market corrections, but overall sentiment remains bullish.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors anticipate the company's upcoming earnings report and monitor ongoing labor negotiations with striking workers. Community discussions revolve around potential revenue, EPS, and overall guidance, with some speculating about a possible dividend reinstatement. News of aircraft orders and production updates are also contributing to the conversation surrounding Boeing's future performance.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings ($CLIK) is trending due to strong revenue growth news, fueling speculation of a potential short squeeze given its low float. The community is drawing comparisons to other Hong Kong stocks that have experienced parabolic moves, anticipating a similar run. Some traders caution about the stock's history of volatility while others point to its small float and high insider ownership as indicators of a potential breakout.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv ($FI) is trending due to a mix of reactions to earnings and new stablecoin initiatives. While some view the stock as oversold and poised for a rebound, others are concerned about lowered guidance and competitive pressures, particularly concerning the Clover platform. The community is actively discussing the implications of Fiserv's new FIUSD stablecoin and its partnerships with Mastercard and PayPal.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene Corp. is trending as investors discuss the potential impacts of a looming government shutdown and the extension of ACA subsidies on the healthcare sector. Community sentiment appears bullish, with many anticipating a positive outcome from budget negotiations and a subsequent rise in stock price. Some traders are closely watching support and resistance levels, while others are focused on the company's long-term earnings potential.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending amid discussions about its AI capabilities, particularly following news of a partnership with Nvidia. The community is weighing bullish sentiments against valuation concerns, with some citing CEO Karp's vision and potential for long-term growth, while others point to traditional metrics suggesting the stock is overvalued. Broader AI sector partnerships and upcoming earnings are also driving interest in the stock.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amid discussions about its partnership with NVIDIA and Uber, with some seeing it as a potential catalyst for growth in autonomous vehicle technology. Community members are weighing the partnership's potential impact against concerns of dilution and production capabilities. The stock's movement has spurred debate on whether it can sustain its gains in the competitive EV sector.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors discuss its potential earnings beat driven by soaring Azure demand and its key role in the AI revolution through its OpenAI partnership. Community chatter highlights Microsoft's steady growth, its upcoming earnings, and potential benefits from AI and cloud services, while also mentioning competition from smaller AI-focused companies. Discussions also involve wider market dynamics, with focus on potential interest rate cuts and upcoming economic data releases.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending after news of a significant investment from NVDA, with the community discussing the potential impact on its valuation and future in AI-driven telecom. Some traders are holding long positions, citing Nokia's valuable patents and potential for growth in the 5G and 6G sectors, while others are taking profits or expressing caution due to the company's large float.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf ($WULF) is trending due to its strategic move into AI data centers, highlighted by a major joint venture with Google-backed Fluidstack. Community discussions focus on the potential short squeeze, with many believing the company's transition from Bitcoin mining to AI infrastructure play justifies higher valuations and will pressure shorts. Bullish sentiment is fueled by analysts raising price targets and anticipation of long-term revenue visibility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment

GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment. Built for simplicity and transparency, GoodRx...

Bank of America Securities said GoodRx’s long-term outlook will depend on how it adapts to a rapidly evolving prescription drug market, as the Trump administration intensifies efforts to shift pricing away from list prices toward net prices.The firm maintained an ‘Underperform’ rating on GoodRx, saying “the popping of the gross-to-net bubble is a negative for GoodRx’s original business model.” It added that the company’s success will depend on how it navigates this “rapidly evolving market.”The bank’s research arm said it does not “have a strong view at this time” on the potential upside or downside from GoodRx’s reported discussions with the Trump administration about joining the new TrumpRx platform.&nbsp;The initiative, expected to launch next year, aims to let consumers buy brand-name drugs directly from pharmaceutical companies such as Pfizer and Amgen at negotiated insurer-level prices, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/us-pharmacies-drug-discounters-are-discussing-trumprx-role-with-administration-2025-10-09/">report</a>.The Trump administration is reportedly pressuring manufacturers and pharmacy benefit managers to abandon list pricing and expand U.S. manufacturing, with steep tariffs threatened for companies that fail to comply. TrumpRx was introduced at a White House event last week as part of that effort to help Americans access cheaper medications, though officials said details are still being finalized.GoodRx CEO Wendy Barnes said that the administration understands that “if we include the pharma direct programs, we also have to find a way to convey competitive cash pricing at retail pharmacies.”Industry groups such as the National Community Pharmacists Association and the National Association of Chain Drug Stores have also been in talks with officials about ensuring that the same discounted prices are available to consumers at local pharmacies.On Stocktwits, retail sentiment for GoodRX was ‘extremely bullish’ amid a 13,400% surge in 24-hour message volume.One user suggested the recent developments might reflect either management preparing for a major move or signaling an upcoming launch, noting the stock’s steady trend of higher highs and lows and arguing that low-cost healthcare offerings make sense in today’s market.&nbsp;<stembedurl>https://stocktwits.com/HOSTILE/message/631753526</stembedurl>Another user commented that investors should stay patient, expressing confidence that GoodRx would eventually strike a deal likely to attract millions of new customers, while adding that even a pullback to support levels would present limited downside risk.<stembedurl>https://stocktwits.com/GSTX7/message/631723527</stembedurl><a href="https://stocktwits.com/symbol/GDRX">GoodRX’s stock</a> has declined 0.2% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the GoodRx Holdings logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

GoodRx Stock Buzzes As TrumpRx Drug Pricing Shake-Up Draws BofA Warning On Core Business Model

BofA Securities said GoodRx’s future hinges on how it adapts to the Trump administration’s TrumpRx plan and the broader shift toward net drug pricing.

Equity

Hims & Hers Expands Personalized Care Access Via Telehealth Platform

HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.

GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call

GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after...

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%

AMGN rolls out AmgenNow, a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.

Amgen (AMGN) announced on Monday that eligible patients can access its drug Repatha at about a 60% discount from the current list price via its direct-to-patient program in the U.S.The program, called AmgenNow, follows the Trump Administration’s push to lower drug prices in the U.S. Repatha will be available through the platform at a monthly cost of $239, Amgen <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/amgen-makes-repatha-available-through-amgennow-a-direct-to-patient-program-in-the-us-302575486.html">said</a>. The company noted that the program is open to all patients, including those who are uninsured or in high-deductible health plans or prefer to pay with cash or out of pocket.The company also noted that the new direct-to-patient price is the lowest among the economically developed countries and is being offered solely to U.S. patients.Amgen’s Repatha is indicated for lowering low-density lipoprotein cholesterol, commonly referred to as “bad” cholesterol.Shares of the company traded over 1% lower at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AMGN">AMGN stock</a> stayed within the ‘bullish’ territory over the past 24 hours, while message volume fell from ‘high’ to ‘normal’ levels.Amgen announced on Monday that it intends to make its direct-to-consumer platform accessible via the TrumpRx website, which was announced by the President last week and is slated for launch next year. The site will enable American consumers to purchase prescription drugs from pharmaceutical companies at a discount.In the second quarter of 2025, Repatha sales increased 31% year-over-year to $696 million, driven by 36% volume growth. This represented nearly 7.6% of the company’s overall revenue in the period.The announcement comes on the heels of President Trump sending letters to 17 drugmakers, including Amgen, in July, demanding that they lower drug prices in the U.S. to levels comparable to those paid by other wealthy nations. Amgen announced on Monday that it would add other drugs to its AmgenNow platform.Separately, the medication savings platform GoodRx (GDRX) also said on Monday that patients can use the platform to access Repatha for $239 at more than 70,000 pharmacies U.S.-wide.AMGN stock is up by 14% this year but down by about 7% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-listed-nyxoah-shares-soar-on-first-genio-system-implants-in-patients-with-sleep-disorder/ch6R4LYR3g1">US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The company logo and the lettering of the biotechnology company Amgen can be seen on the facade of the company's headquarters in Munich (Bavaria) on January 14, 2025. Photo: Matthias Balk/dpa (Photo by Matthias Balk/picture alliance via Getty Images)

Amgen To Sell Cholesterol Drug For Approximately 60% Discount 

Patients can purchase Repatha at a discount through Amgen’s direct-to-patient program, AmgenNow. 

Hims & Hers Expands AI and Technology Focus to Advance Digital Care

HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.

U.S. equities edged lower in Monday’s midday trade as investors turned cautious ahead of Federal Reserve Chair Jerome Powell’s speech at the Jackson Hole symposium on Friday.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was down 0.08% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq, fell 0.19%.Here are the top stocks making the biggest moves in Monday’s midday trade:<a href="https://stocktwits.com/symbol/DAY">Dayforce Inc. (DAY)</a>Dayforce shares skyrocketed 26% in Monday’s midday trade after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/thoma-bravo-eyes-takeover-of-hr-software-firm-dayforce-report/chsaxunRdQJ">reports</a> suggested that private equity firm Thoma Bravo is in talks to acquire the human resources firm.<a href="https://stocktwits.com/symbol/DAY">DAY stock</a> is down 8% year-to-date.<a href="https://stocktwits.com/symbol/APLD">Applied Digital Corp. (APLD)</a>Applied Digital shares gained over 14% in Monday’s midday trade after it&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/this-data-center-stock-doubled-in-2025/chsOWqERdX9">announced</a> plans to begin construction of its next-generation $3 billion AI campus, Polaris Forge 2, in September.<a href="https://stocktwits.com/symbol/APLD">APLD stock</a> is up 111% year-to-date.<a href="https://stocktwits.com/symbol/GDRX">GoodRx Holdings Inc. (GDRX)</a>GoodRx shares surged over 35% in Monday’s midday trade after Novo Nordisk&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-cuts-ozempic-cost-to-499-dollars-per-month-for-self-paying-patients/chsOfKDRdXE">announced</a> a collaboration with the drug savings platform to provide self-paying eligible type 2 diabetes patients with access to Ozempic at $499.<a href="https://stocktwits.com/symbol/GDRX">GDRX stock</a> is up 8% year-to-date.<a href="https://stocktwits.com/symbol/FSLR">First Solar Inc. (FSLR)</a>First Solar shares surged nearly 9% in Monday’s midday trade as investors cheered the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/solar-incentives-treasury-clears-the-air-fslr-run-enph-nee-stocks-in-focus/chsOJX1RdQy">clarity offered</a> by the U.S. Treasury Department and the Internal Revenue Service regarding wind and solar incentives. Shares of other clean energy companies, like SolarEdge Technologies Inc. (SEDG), Sunrun Inc. (RUN), Enphase Energy Inc. (ENPH), and NextEra Energy Inc. (NEE), also rose.<a href="https://stocktwits.com/symbol/FSLR">FSLR stock</a> is up 23% year-to-date.<a href="https://stocktwits.com/symbol/WULF">TeraWulf Inc. (WULF)</a>TeraWulf shares surged more than 11% in Monday’s midday trade after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/terawulf-launches-400-million-convertible-note-offering/chsO7yLRdQx">announced</a> plans to raise $400 million through a private offering of convertible senior notes due in 2031. Alphabet Inc.’s (GOOG/GOOGL) Google also extended its backstop to $3.2 billion from $1.8 billion, with its stake in the company increasing to nearly 14%.<a href="https://stocktwits.com/symbol/WULF">WULF stock</a> is up 76% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/jpmorgan-warns-investors-be-prepared-goldilocks-dominating-equity-markets/chsOiYdRdXg">JPMorgan Warns Investors To Brace For Incoming Volatility, Says ‘Goldilocks’ Narrative Still Dominating Markets: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Dayforce, Applied Digital, GoodRx, First Solar, TeraWulf: Stocks Making The Biggest Moves Today

Dayforce shares skyrocketed 26% in Monday’s midday trade after reports suggested that private equity firm Thoma Bravo is in talks to acquire the human resources firm.

Danish drugmaker Novo Nordisk (NVO) has announced that it will allow self-paying eligible type 2 diabetes patients access to its Ozempic for $499 per month starting Monday via multiple platforms, including drug savings platform GoodRx (GDRX).The new offer aims to assist Type 2 diabetes patients who are uninsured or choose to self-pay, and may potentially face prices at or above wholesale cost. The offer will also be available through the company’s online pharmacy, NovoCare, as well as the drug’s official website.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-slashes-full-year-guidance/cho9UwAR5yE">NVO</a> jumped from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume remained at ‘normal’ levels. Shares of the company traded 5% higher on Monday morning at the time of writing.The offer comes as the company battles the compounding of its blockbuster medicines. Last month, Novo lowered its full-year 2025 outlook, citing lower growth expectations for its blockbuster weight loss drug Wegovy and Ozempic for the second half of the year. While the U.S. Food and Drug Administration has prohibited mass compounding for the active component in Wegovy and Ozempic called Semaglutide, unsafe and unlawful mass compounding has continued, the company said, citing its market research.“We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many. This is why we felt it was important to make Ozempic, the GLP-1 with the broadest range of FDA-approved indications for adults with type 2 diabetes, more affordable to those without insurance who deserve the real thing," <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk-us.com/media/news-archive/news-details.html?id=916418">said</a> Dave Moore, Executive Vice President, U.S. Operations of Novo Nordisk Inc.As part of Novo’s collaboration with GoodRx, self-paying patients can get all strengths of both Wegovy and Ozempic for $499 per month through the GoodRx platform. Eligible patients can use GoodRx to self-pay for Ozempic and Wegovy pens for $499 per month at over 70,000 retail pharmacies nationwide, the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.goodrx.com/news-releases/news-release-details/goodrx-announces-collaboration-novo-nordisk-expand-access">said</a>. Shares of <a href="https://stocktwits.com/symbol/GDRX">GDRX </a>traded 31% higher following the news.While NVO stock is down by 37% this year, GDRX is up by 5%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/lakeshore-biopharma-got-an-acquisition-proposal-from-oceanpine-capital/chsO9ANRdXT">LakeShore Biopharma Just Got An Acquisition Proposal From Oceanpine Capital: More Details Inside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Novo Nordisk logo is displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Novo Nordisk Stock Surges After Pharma Major Cuts Ozempic Cost to $499 Per Month For Self-Paying Patients

The new offer aims to assist Type 2 diabetes patients who are uninsured or choose to self-pay, and may potentially face prices at or above wholesale cost.

Compared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics

The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.

GoodRx Holdings Inc - Ordinary Shares - Class A

Will Meta ($META) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Meta Platforms Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

GDRX
GoodRx Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GDRX News

GDRXGoodRx Holdings Inc